Hypertension Market to Expand at a Significant Growth Rate During the Forecast Period (2019-32) - Estimates DelveInsight | Mineralys, Alnylam, Ionis, Aerovate, Novartis, Cereno, JeniVision, Merck, AbbVie, Acceleron, Gossamer, Insmed, Altavant, Bayer

As per DelveInsight, the Hypertension Market is anticipated to evolve immensely in the coming years owing to the increasing global prevalence of hypertension. The rising prevalence has fueled the demand for better treatment options that effectively address hypertension and its complications. There has been a notable rise in the market size of hypertension in recent years, which is majorly driven by advancements in research and development and the introduction of innovative drugs and therapies for hypertension by pharma giants.

DelveInsight's "Hypertension Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Hypertension Market Size and Share in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).

The market report covers emerging drugs, treatment practices, market share of individual Hypertension therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current Hypertension treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.

Hypertension: An Overview
Hypertension, commonly known as high blood pressure, is a chronic medical condition characterized by elevated levels of blood pressure in the arteries. Prevalence and Impact: Hypertension is a global health concern affecting a significant portion of the population. Its prevalence has been increasing steadily over the years, primarily due to lifestyle factors such as poor diet, sedentary behavior, and stress. Hypertension is a major risk factor for various cardiovascular diseases, including heart attacks, strokes, and heart failure. It also contributes to the development of kidney disease and can affect other organs such as the eyes.

Hypertension is classified into two main types: primary (essential) hypertension and secondary hypertension. Primary hypertension is the most common form, accounting for approximately 90-95% of cases, and its exact cause is often unknown. Secondary hypertension results from an identifiable underlying medical condition, such as kidney disease, hormonal disorders, or the use of certain medications. Hypertension Monitoring and Control: Regular monitoring of blood pressure is essential for individuals with hypertension. This can be done at home using home blood pressure monitors or through regular check-ups with healthcare professionals. Blood pressure control is typically defined as achieving and maintaining a target blood pressure level (usually below 130/80 mmHg) through a combination of lifestyle changes and medications, if necessary.

To improve the Hypertension treatment scenario, several companies such as Mineralys Therapeutics Inc, CinCor Pharma, and others are developing their assets in the mid-late stage of development. With the expected approval of these therapies, the Hypertension therapeutics market is anticipated to evolve immensely in the upcoming years.

Hypertension Market Key Facts
• According to CDC (2021), nearly half of adults in the United States (47%) have hypertension, defined as a systolic blood pressure greater than 130 mmHg or a diastolic blood pressure greater than 80 mmHg or are taking medication for hypertension.
• According to WHO (2023), the prevalence of hypertension shows regional and income group variations, with the WHO Region of the Americas exhibiting the lowest prevalence of hypertension at 18%. Different regions and countries display varying rates of hypertension.
• According to Okui et al. (2022), the current prevalence of hypertension is approximately 30% and 20%, respectively, for men and women aged 20 or more years in Japan.

Discover How Hypertension Market Will Grow by 2032:
https://www.delveinsight.com/report-store/hypertension-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Hypertension Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted market size by analyzing the impact of current and emerging Hypertension therapies in the market. It also provides a detailed assessment of the Hypertension market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the market trend for each marketed Hypertension drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MOA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Hypertension Epidemiology
The epidemiology section covers detailed insights into the historical, and current Hypertension patient pool and forecasted epidemiology trends for every seven major countries (7MM) from 2019 to 2032.

The Report Covers the Hypertension Epidemiology Segmented as -
• Diagnosed Prevalent Cases of Hypertension
• Gender-specific Diagnosed Prevalent Cases of Hypertension
• Age-specific Diagnosed Prevalent Cases of Hypertension
• Severity-specific Diagnosed Prevalent Cases of Hypertension

Get Key Insights Into the Evolving Hypertension Epidemiology Trends:
https://www.delveinsight.com/report-store/hypertension-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Hypertension Drugs Uptake and Pipeline Development Activities
The drugs' uptake section focuses on the rate of uptake of the potential drugs recently launched in the Hypertension market or expected to be launched during the study period. The analysis covers the market share by Hypertension drugs, patient uptake by therapies, and sales of each drug.

The report's drugs uptake section helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs. It allows the comparison of the drugs based on market share and size, which again will be helpful in investigating factors important in understanding the market dynamics and in making financial and regulatory decisions.

The report also covers the Hypertension Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Explore More About Ongoing Pipeline Development Activities:
https://www.delveinsight.com/sample-request/hypertension-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Hypertension Therapeutics Assessment
Several major pharma and biotech companies are developing therapies for Hypertension. Currently, Reata Pharmaceuticals is leading the therapeutics market with its Hypertension drug candidates in the most advanced stage of clinical development.

Leading Companies in the Hypertension Therapeutics Market Include
Quantum Genomics, CinCor Pharma, Mineralys Therapeutics, Alnylam Therapeutics, Ionis Pharmaceuticals, Future Medicine, Pharmosa BioPharm, Aerovate Therapeutics, Novartis, Cereno Scientific AB, Torrent Pharmaceuticals Limited, JeniVision, Inc., Merck Sharp & Dohme LLC, AbbVie, Acceleron Pharma Inc., Hanmi Pharmaceutical Company Limited, Gossamer Bio Inc., Shanghai Pharmaceuticals Holding Co., Ltd, Insmed Incorporated, Gmax Biopharm LLC., Altavant Sciences GmbH, Bayer, Respira Therapeutics, Inc., Aadi Bioscience, Inc., Boehringer Ingelheim, JW Pharmaceutical, PRM Pharma, LLC, PolyActiva Pty Ltd, pH Pharma, Nicox Ophthalmics, Inc., Ocular Therapeutix, Inc., Santen SAS, Whitecap Biosciences, LLC, Chong Kun Dang Pharmaceutical, AJU Pharm Co., Ltd., Laboratoires Thea, Aerami Therapeutics, KBP Biosciences, Cumberland Pharmaceuticals, Vigonvita Life Sciences, IlDong Pharmaceutical Co Ltd, Qlaris Bio, Inc., and many others.

Emerging and Marketed Hypertension Therapies Covered in the Report Include
• Firibastat: Quantum Genomics
• Baxdrostat (CIN-107): CinCor Pharma
• MLS-101: Mineralys Therapeutics
• Zilebesiran (ALN-AGT): Alnylam Therapeutics
• Lorundrostat: Mineralys Therapeutics Inc.
• BAXDROSTAT: CinCor Pharma
And Many More

Learn More About the Emerging Therapies & Key Companies in the Hypertension Therapeutics Market:
https://www.delveinsight.com/sample-request/hypertension-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Hypertension Competitive Intelligence Analysis
4. Hypertension Market Overview at a Glance
5. Hypertension Background and Overview
6. Hypertension Patient Journey
7. Hypertension Epidemiology and Patient Population
8. Hypertension Treatment Algorithm, Current Treatment, and Medical Practices
9. Hypertension Unmet Needs
10. Key Endpoints of Hypertension Treatment
11. Hypertension Marketed Products
12. Hypertension Emerging Therapies
13. Hypertension Seven Major Market Analysis
14. Attribute Analysis
15. Hypertension Market Outlook (7 major markets)
16. Hypertension Access and Reimbursement Overview
17. KOL Views on the Hypertension Market.
18. Hypertension Market Drivers
19. Hypertension Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.

Download the Sample PDF to Get Detailed Insights About the Report's Offerings:
https://www.delveinsight.com/sample-request/hypertension-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

-------------------------------------------- xx --------------------------------------------
Other Trending Healthcare Reports by DelveInsight -
Messenger RNA (mRNA)-based Vaccines and Therapeutics Market
https://www.delveinsight.com/report-store/global-messenger-rna-mrna-based-vaccines-and-therapeutics-market

Narcolepsy Market
https://www.delveinsight.com/report-store/narcolepsy-market

Osteoporosis Market
https://www.delveinsight.com/report-store/osteoporosis-market

Carcinoid Tumor Syndrome Market
https://www.delveinsight.com/report-store/carcinoid-tumor-syndrome-market

Migraine Market
https://www.delveinsight.com/report-store/migraine-market

Emphysema Market
https://www.delveinsight.com/report-store/emphysema-market

Substance use disorder Market
https://www.delveinsight.com/report-store/substance-use-disorder-market

Tumor Ablation Market
https://www.delveinsight.com/report-store/tumor-ablation-market

Campylobacter Infections Market
https://www.delveinsight.com/report-store/campylobacter-infections-market

mRNA Vaccine and Therapeutics Market
https://www.delveinsight.com/report-store/mrna-vaccine-and-therapeutics-market

Breast Pumps Market
https://www.delveinsight.com/report-store/breast-pumps-market

Negative Pressure Wound Therapy Systems Market
https://www.delveinsight.com/report-store/negative-pressure-wound-therapy-systems-market

Obsessive-Compulsive Disorder Market
https://www.delveinsight.com/report-store/obsessive-compulsive-disorder-market

Diabetic Eye Disease Market
https://www.delveinsight.com/report-store/diabetic-eye-disease-market

Seborrhoeic Dermatitis Market
https://www.delveinsight.com/report-store/seborrhoeic-dermatitis-market

Hernia Repair Devices Market
https://www.delveinsight.com/report-store/hernia-repair-devices-market

Contact Info:
Shruti Thakur
Manager (Marketing & Branding)
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.